Clayton Partners LLC Soleno Therapeutics Inc Transaction History

Clayton Partners LLC

  • $125 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
BUY
$0.16 - $2.48 $16,000 - $248,000
100,000 New
100,000 $167,000
Q2 2021

Aug 13, 2021
SELL
$0.97 - $1.32 $97,000 - $132,000
-100,000 Closed
0 $0
Q1 2021

May 12, 2021
BUY
$1.24 - $3.3 $124,000 - $330,000
100,000 New
100,000 $126,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $388M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Clayton Partners LLC Portfolio

Follow Clayton Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clayton Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clayton Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email